INCORPORACIÓN DE NUEVAS ÁREAS TEMÁTICAS Y NUEVOS GRUPOS AL CONSORCIO CIBER
Datos básicos
- Protocolo:
- CB16/12/00484
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
Resultados del Ensayo Clínico
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.
Siaw, Joachim Tetteh; (...); Martinsson, Tommy
Article. 10.1016/j.celrep.2020.108171. 2020
Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines.
López-Carrasco, A; (...); Noguera, R
Article. 10.3390/cancers16193347. 2024
Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.
Sanegre, S; (...); Noguera, R
Article. 10.3389/fcell.2021.670185. 2021
Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models.
Monferrer, Ezequiel; (...); Noguera, Rosa
Article. 10.3390/ijms21228676. 2020
Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma
Stoks, M; (...); Noguera, R
Article. 10.1016/j.compbiomed.2023.107364. 2023
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Bellini, Angela; (...); Schleiermacher, Gudrun
Article. 10.1200/JCO.21.00086. 2021
High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.
Monferrer E; (...); Noguera R
Article. 10.1186/s12885-018-5219-3. 2019
Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.
Fernandez-Blanco, Beatriz; (...); Noguera, Rosa
Article. 10.1016/j.neo.2020.11.001. 2020
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.
Sonzini, Giorgia; (...); Noguera, Rosa
Article. 10.3389/fcell.2022.1052098. 2022
Integrating the Tumor Microenvironment into Cancer Therapy.
Sanegre, Sabina; (...); Alvaro Naranjo, Tomas
Article. 10.3390/cancers12061677. 2020
Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.
Lopez-Carrasco, Amparo; (...); Noguera, Rosa
Article. 10.3390/cancers13205173. 2021
Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.
Monferrer, Ezequiel; (...); Alvaro Naranjo, Tomas
Article. 10.3390/metabo11050264. 2021
Real-time morphometric analysis of targeted therapy for neuroblastoma cells in monolayer and 3D hydrogels using digital holographic microscopy.
Granados-Aparici, S; (...); Noguera, R
Article. 10.1016/j.isci.2024.111231. 2024
Risk of developing neuroblastoma influenced by maternal stressful life events during pregnancy and congenital pathologies
Benavent N; (...); Tadeo I
Article. 10.1002/pbc.31402. 2025
SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology Images.
Zormpas-Petridis, K; (...); Yuan, YY
Article. 10.3389/fonc.2020.586292. 2021
The complexity of cancer immunotherapy illustrated through skin tumors.
Vieco-Marti, I; (...); Alvaro Naranjo, T
Article. 10.1177/03936155221088884. 2022
The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection
Vicente-Munuera, P; (...); Escudero, LM
Article. 10.1002/ijc.32495. 2020
The tumour microenvironment as an integrated framework to understand cancer biology
Burgos-Panadero, R; (...); Noguera, R
Review. 10.1016/j.canlet.2019.07.010. 2019
Therapeutic Opportunities in Neuroblastoma Using Nanotechnology
Rodriguez-Nogales, C; (...); Blanco-Prieto, MJ
Review. 10.1124/jpet.118.255067. 2019
Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma.
Burgos-Panadero, Rebeca; (...); Noguera, Rosa
Article. 10.1016/j.ijpharm.2021.121058. 2021
Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
Burgos-Panadero, R; (...); Noguera, R
Article. 10.1186/s12885-019-5693-2. 2019
Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?
López-Carrasco A; (...); Noguera R
Article. 10.3390/ijms25168733. 2024